Skip to main content

Tag: Peter J. Dunn Award

Amgen

Improving Efficiency and Sustainability of the Olpasiran Drug Substance Process

Improving Efficiency and Sustainability of the Olpasiran Drug Substance Process

2026 Peter J. Dunn Award for Green Chemistry & Engineering Impact in the Pharmaceutical Industry – Large Molecule

Amgen‘s Olpasiran team is recognized for developing a more efficient and environmentally responsible manufacturing process for olpasiran, a GalNAc‑conjugated siRNA therapeutic. Guided by green chemistry principles, the team streamlined multiple stages of the synthetic route, including starting material preparation, GalNAc ligand synthesis, and the conjugation process. Through targeted optimization, hazardous solvents and reagents were replaced with safer, lower‑risk alternatives, while maintaining or improving process yields. These enhancements were successfully demonstrated at multi‑kilogram scale (>30 kg), ensuring both scalability and robustness.

The optimized process delivers substantial sustainability benefits: up to a 37% reduction in E‑factors and more than 25% reduction in solvent and waste at peak production levels. This work highlights how thoughtful process redesign can significantly decrease environmental impact while enabling reliable, large‑scale manufacturing of advanced RNA therapeutics.

Amgen

Team Members

  • Janine Tom
  • Edward Helbling
  • Meagan Hackey
  • Timur Berilo
  • Amanda Stahl
  • Shea O’Sullivan
  • Heather Johnson
  • Andrew Cosbie
  • Bharath Venkatram
  • Yan Chen
Amgen's Olpasiran team Amgen‘s Olpasiran team

More about the Award

The Peter J. Dunn Award, established in 2016, recognizes outstanding industrial implementation of novel green chemistry and/or engineering in the pharmaceutical industry that demonstrates compelling environmental, safety, cost, and/or efficiency improvements over current technologies.

This annual award is presented at the Green Chemistry & Engineering Conference, where presenters are invited to share their innovations. 

Continue reading

Bristol Myers Squibb

Sustainable Manufacturing of Repotrectinib API – BMS-986472

Sustainable Manufacturing of Repotrectinib API – BMS-986472

2026 Peter J. Dunn Award for Green Chemistry & Engineering Impact in the Pharmaceutical Industry – Small Molecule

The Bristol Myers Squibb team is recognized for a breakthrough redesign of the manufacturing route for Repotrectinib (BMS 986472) API, delivering major sustainability and efficiency gains through green chemistry innovation. By integrating retrosynthetic redesign with environmentally conscious process optimization, the team achieved a fourfold yield improvement, from 11% to 45%, while reducing isolations from ten to six and fully eliminating dioxane and all halogenated solvents and reagents. The introduction of a second-generation biocatalytic route for a key raw material further demonstrates a shift toward cleaner, renewable, low-impact technologies.

These combined efforts drove 43–73% reductions across multiple life cycle assessment metrics, including cycle time, cost per kilogram, Process Mass Intensity, Mass Net, energy consumption, CO₂ emissions, and water depletion. The project showcases how sustainable design and operational excellence can coexist to deliver greener, more responsible pharmaceutical manufacturing.

Bristol Myers Squibb

Team Members

  • Richard Fox
  • Steven Wisniewski
  • Adam Freitag
  • Yichen Tan
  • Daniel Treitler
  • Hester Dang
  • Geoff Purdum
  • Bilal Hoblos
  • Troy Wilkens
  • Keming Zhu
  • Yiming Yang (Asymchem)

More about the Award

The Peter J. Dunn Award, established in 2016, recognizes outstanding industrial implementation of novel green chemistry and/or engineering in the pharmaceutical industry that demonstrates compelling environmental, safety, cost, and/or efficiency improvements over current technologies.

This annual award is presented at the Green Chemistry & Engineering Conference, where presenters are invited to share their innovations. 

Continue reading

From Bottleneck to Breakthrough: Developing a Sustainable and Scalable Manufacturing Process for a Complex ADC Drug-Linker

2025 Peter J. Dunn Award for Green Chemistry & Engineering Impact in the Pharmaceutical Industry

The Merck team, consisting of Patrick Fier, Patrick Moon, Scott McCann, Tao Liang, Greg Estrada, Marc Poirier, Reed Larson, Lu Wang, Gao Shang, and Fuh-Rong Tsay, received this award for their work, “From Bottleneck to Breakthrough: Developing a Sustainable and Scalable Manufacturing Process for a Complex ADC Drug-Linker”. They demonstrated the impact of applying green chemistry principles in the manufacturing process of the linker for the antibody-drug conjugate (ADC) Sacituzumab tirumotecan (MK-2870). Originally, the manufacturing process had long lead times due to the 20-step synthetic sequence and faced a major bottleneck with the final purification that limited production to less than 100 g per month even with 24/7 operation in a high-potency chromatography suite. Major improvements were achieved by developing a synthesis from a widely available natural product that cut seven potent steps down to three. The Process Mass Intensity (PMI) was reduced by approximately 75%, and the amount of energy-intensive chromatography time was decreased by >99% compared to the original route. This work highlights the advantages of investing in greener and more sustainable processes that naturally improve the global supply of medicines to patients.

Merck

More about the Award

The Peter J. Dunn Award, established in 2016, recognizes outstanding industrial implementation of novel green chemistry and/or engineering in the pharmaceutical industry that demonstrates compelling environmental, safety, cost, and/or efficiency improvements over current technologies.

This annual award is presented at the Green Chemistry & Engineering Conference, where presenters are invited to share their innovations. 

Continue reading

A Sustainably-Designed Manufacturing Process to Adavelt™ Active from Renewable Feedstocks.

2025 Peter J. Dunn Award for Green Chemistry & Engineering Impact in the Pharmaceutical Industry

Corteva

Corteva’s winning submission “A Sustainably-Designed Manufacturing Process to Adavelt™ Active from Renewable Feedstocks.” The Corteva team demonstrated the design of an efficient manufacturing process for Adavelt™ active, with sustainability as a core focus. They adopted green chemistry principles to maximize yield, reduce waste, and deliver a cost-effective solution for farmers. Building upon the first-generation supply route, they developed a process that eliminated three protecting groups, four steps, the use of precious metals, and replaced undesirable reagents with greener alternatives while producing an active ingredient effective against 20 diseases in over 30 crops.

More about the Award

The Peter J. Dunn Award, established in 2016, recognizes outstanding industrial implementation of novel green chemistry and/or engineering in the pharmaceutical industry that demonstrates compelling environmental, safety, cost, and/or efficiency improvements over current technologies.

This annual award is presented at the Green Chemistry & Engineering Conference, where presenters are invited to share their innovations. 

Continue reading

Development of a short and eco-friendly asymmetric manufacturing process for Spiroketone CD 7659

2024 Peter J. Dunn Award for Green Chemistry & Engineering Impact in the Pharmaceutical Industry

The Boehringer Ingelheim team—Yongda Zhang, Eugene Chong, Jada White, Suttipol Radomkit, Yibo Xu, Jon Lorenz, and Linglin Wu—was selected for their innovative work developing a short and eco-friendly manufacturing process for Spiroketone CD 7659—a common intermediate used in multiple projects within the company. The team’s new 3-step asymmetric synthesis route improved the yield nearly five-fold from 10 to 47 percent, reduced organic solvent usage by 99 percent, eliminated use of halogenated solvent, and reduced water usage by 76 percent. The sustainability achievements were further highlighted by a PMI of 117, 72 percent Relative Process Greenness (RPG) score, and an “excellent” innovation Green Aspiration Level (iGAL), placing it in the top 10 percent of industry processes. The team highlighted that their process can be scaled to meet and exceed a projected demand of more than 13 tons of the product which will result in saving more than 69,327,473 kg of waste compared to the initial process for one project.

Figure: This iGAL 2.0 scorecard shows the sustainability improvements of Boehringer Ingelheim’s new process for manufacturing Spiroketone CD 7659 over the incumbent process.

Image shows an iGAL 2.0 scorecard.

More about the Award

The Peter J. Dunn Award, established in 2016, recognizes outstanding industrial implementation of novel green chemistry and/or engineering in the pharmaceutical industry that demonstrates compelling environmental, safety, cost, and/or efficiency improvements over current technologies.

This annual award is presented at the Green Chemistry & Engineering Confernece where presenters are invited to share their innovations. 

Pictured: Yongda Zhang, Distinguished Research Fellow at Boehringer Ingelheim, accepts 2024 Pete Dunn Award from Isamir Martinez (ACSGCI) and ACS GCIPR 2024 Co-Chair, Dan Bailey of Takeda.

Yongda Zhang receives Peter J. Dunn Award on behalf of Boehringer Ingelheim.

Continue reading

Development of a More Sustainable 2nd Generation Route to Peptide-Maleimidocaproyl MonoMethyl Auristatin F (mcMMAF)-the Cytotoxic Payload for Blenrep®, A Novel Antibody Conjugate Drug (ACD) for the Treatment of Multiple Myeloma

2024 Peter J. Dunn Award for Green Chemistry & Engineering Impact in the Pharmaceutical Industry

GSK’s winning submission demonstrated a more sustainable peptide manufacturing route for maleimidocaproyl monomethyl auristatin F (mcMMAF)—a drug used to treat multiple myeloma, a rare cancer affecting plasma cells. GSK team members being recognized are Danny Mancheno, Ian Andrews, Qiaogong Su, Kenneth Arrington, Mark Mellinger, Gregory Gilmartin, Aleksey Karulin, Anthony Nocket, John Kowalski, John Woodard (Collegeville, Pa.), and Chris Thickitt (Stevenage, UK). The first-generation route had already been commercialized and filed with the FDA however, GSK determined a more efficient route was needed. The team took on this complex challenge and developed a 2nd generation route that reduced solvent consumption by 16,160 kgs for every kilogram, greenhouse gas emissions by 71 percent, and energy consumption by 76 percent. Additionally, the route eliminated all single-use silica gel chromatographic separations, achieving an overall 76 percent reduction in Process Mass Intensity (PMI).

First Generation Process to McMMAF

More about the Award

The Peter J. Dunn Award, established in 2016, recognizes outstanding industrial implementation of novel green chemistry and/or engineering in the pharmaceutical industry that demonstrates compelling environmental, safety, cost, and/or efficiency improvements over current technologies.

This annual award is presented at the Green Chemistry & Engineering Confernece where presenters are invited to share their innovations. 

Pictured: Danny E. Mancheno, Principal Investigator at GSK, accepts 2024 Pete Dunn Award from Isamir Martinez (ACSGCI) and ACS GCIPR 2024 Co-Chair, Dan Bailey of Takeda.

2024 Pete Dunn Award Winner - GSK

Continue reading